Perrigo Gets FDA Approval To Sell Cinnamon Nicotine Gum
Allegan-based Perrigo Co. (Nasdaq: PRGO) announced that it has received approval from the United States Food and Drug Administration to market over-the-counter coated nicotine polacrilex gum USP, 2 mg and 4 mg cinnamon flavor.
The product will be marketed under store brand labels and is comparable to GlaxoSmithKline’s Nicorette Cinnamon Surge coated gum, which is a stop smoking aid.
“This approval of coated cinnamon nicotine gum extends our leading store brand position,” said Perrigo chairman and CEO Joseph C. Papa. “The expanded range of smoking cessation products also includes coated mint-flavored gum, coated fruit wave, uncoated gum and lozenges.
Nicorette Cinnamon Surge gum is selling at an annual rate estimated at over $40 million at all retail outlets.
First shipments are expected to ship this fall.
Perrigo develops, manufactures and distributes over-the-counter and generic prescription pharmaceuticals, infant formulas, nutritional products, active pharmaceutical ingredients and pharmaceutical and medical diagnostic products. The company is the world’s largest store brand manufacturer of OTC pharmaceutical products and infant formulas. Perrigo’s primary markets and locations of manufacturing and logistics operations are the United States, Israel, Mexico, the United Kingdom and Australia.
More at www.perrigo.com.